A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Clinical trial NCT05628311 · COMPLETED
Trial details
- NCT number
- NCT05628311
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-06
- Primary completion
- 2023-10-25
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.